But unlike most businesses, its product — marijuana — is still illegal in the eyes of the federal government. That disadvantage will make it harder for Schwazze and other cannabis companies to ...

A recent study of cannabis users in the ACT found around 70 per cent won't drive for at least seven hours afterwards. Some drivers are getting behind the wheel after consuming cannabis ...

Inside the $32 billion industry transforming marijuana, its consumption and beliefs about its ability to heal. Credit...Mark Abramson for The New York Times Supported by By Katie J.M. Baker Megan ...

Jan. 28, 2025 — A new study explores the effects of both recent and lifetime cannabis use on brain function during cognitive tasks. The study, the largest of its kind ever to be completed ...

Opinions expressed by Forbes Contributors are their own. Javier Hasse is a cannabis and psychedelics reporter and book author. The cannabis industry owes much of its foundation to one simple but ...

Both hemp and cannabis plants are the same species. The main difference lies in how much of a specific cannabinoid each contains. It’s a common misconception that hemp and cannabis are two ...

Remembering what your boss said. These are examples of your brain’s working memory — and a new study indicates that if you use marijuana more frequently, you could be damaging it. 2️⃣ ...

There is little official guidance on using cannabis after surgery. Research on the effects of cannabis on surgery, anesthesia, and surgical recovery lags behind its use. For this reason ...

Donkey Kong Country Returns HD includes the additional content from the 3DS version. Donkey Kong Country Returns HD does sacrifice the 3D effect that was available on the 3DS version, but it does ...

New research from the University of Colorado Anschutz Medical Campus suggests that heavy lifetime cannabis use may harm working memory in young adults. © 2025 ...

Germany is the third EU country to legalise cannabis, sparking a debate across Europe. Cannabis is the most widely used illicit drug in Europe, with almost a third of adults having tried it at ...